Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Christiane Eder"'
Autor:
Tamara Alpermann, Susanne Schnittger, Christiane Eder, Frank Dicker, Manja Meggendorfer, Wolfgang Kern, Christoph Schmid, Carlo Aul, Peter Staib, Clemens-Martin Wendtner, Norbert Schmitz, Claudia Haferlach, Torsten Haferlach
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Externí odkaz:
https://doaj.org/article/88173d437c0b4497b66403334ca7f505
Autor:
Sabine Jeromin, Torsten Haferlach, Sandra Weissmann, Manja Meggendorfer, Christiane Eder, Niroshan Nadarajah, Tamara Alpermann, Alexander Kohlmann, Wolfgang Kern, Claudia Haferlach, Susanne Schnittger
Publikováno v:
Haematologica, Vol 100, Iss 4 (2015)
Externí odkaz:
https://doaj.org/article/7da4c9c9c672403b9980afb045648b60
Autor:
Annette Fasan, Claudia Haferlach, Alexander Kohlmann, Frank Dicker, Christiane Eder, Wolfgang Kern, Torsten Haferlach, Susanne Schnittger
Publikováno v:
Haematologica, Vol 99, Iss 2 (2014)
Externí odkaz:
https://doaj.org/article/3f7ac65ecf574092b8c62bdc4f5987e3
Autor:
Annette Fasan, Tamara Alpermann, Claudia Haferlach, Vera Grossmann, Andreas Roller, Alexander Kohlmann, Christiane Eder, Wolfgang Kern, Torsten Haferlach, Susanne Schnittger
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e54365 (2013)
The clinical impact of aberrant CEBPA promoter methylation (PM) in AML is controversially discussed. The aim of this study was to clarify the significance of aberrant CEBPA PM with regard to clinical features in a cohort of 623 cytogenetically normal
Externí odkaz:
https://doaj.org/article/5a58d602792a4c1e88be2d40fa767bfc
Autor:
Susanne Schnittger, Ulrike Bacher, Tamara Alpermann, Andreas Reiter, Madlen Ulke, Frank Dicker, Christiane Eder, Alexander Kohlmann, Vera Grossmann, Andreas Kowarsch, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach
Publikováno v:
Haematologica, Vol 97, Iss 12 (2012)
We analyzed 636 patients with diverse myeloproliferative neoplasms or myelodysplastic/myeloproliferative neoplasms for mutations of the Casitas B-cell lymphoma gene (CBLmut) in exons 8 and 9 and performed correlations to other genetic alterations. CB
Externí odkaz:
https://doaj.org/article/fad1dd8c570b40da87aba9d4cecff014
Autor:
Susanne Schnittger, Ulrike Bacher, Christiane Eder, Frank Dicker, Tamara Alpermann, Vera Grossmann, Alexander Kohlmann, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach
Publikováno v:
Haematologica, Vol 97, Iss 10 (2012)
We investigated 15,542 patients with suspected BCR-ABL1- negative myeloproliferative or myelodysplastic/myeloproliferative neoplasm (including 359 chronic myelomonocytic leukemia) by a molecular marker set. JAK2V617F was detected in the suspected cat
Externí odkaz:
https://doaj.org/article/e7313f8a27564a7e872ff41f4f16fb2c
Publikováno v:
International Journal of Laboratory Hematology. 41
Publikováno v:
International journal of laboratory hematology. 41(5)
Autor:
Ulke M, Niroshan Nadarajah, T Haferlach, Ulrike Bacher, Claudia Haferlach, Wolfgang Kern, Frank Dicker, Kuznia S, Susanne Schnittger, Maria Theresa Krauth, Christiane Eder, Tamara Alpermann
Publikováno v:
Leukemia. 29:660-667
To investigate frequency and prognostic impact of Wilms tumor 1 (WT1) mutations (mut), we analyzed 3157 unselected acute myeloid leukemia patients for WT1mut in exons 7 and 9. In total, 188 WT1 mutations were detected (exon 7: n=150, exon 9: n=38); 1
Autor:
Manja Meggendorfer, Torsten Haferlach, Nirsoshan Nadarajah, Sandra Weissmann, Christiane Eder, Susanne Schnittger, Claudia Haferlach, Sabine Jeromin, Alexander Kohlmann, Tamara Alpermann, Wolfgang Kern
Publikováno v:
Haematologica. 100:e125-e127
Refractory anemia with ring sideroblasts and marked thrombocytosis (RARS-T) is a rare entity with characteristics of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).[1][1] Patients have been shown to be frequently JAK2 V61